NCT00218283View on ClinicalTrials.gov

Nicotine Lozenge to Reduce Smokeless Tobacco Use

PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

June 30, 2007

Study Completion Date

June 30, 2007

Conditions
Tobacco Use Disorder
Interventions
DRUG

Nicotine Lozenge

Oral Nicotine replacement product

BEHAVIORAL

Behavioral Counseling

Use of behavioral counseling to reduce tobacco use.

Trial Locations (1)

55455

University of Minnesota, Minneapolis

All Listed Sponsors
collaborator

University of Minnesota

OTHER

lead

National Institute on Drug Abuse (NIDA)

NIH

NCT00218283 - Nicotine Lozenge to Reduce Smokeless Tobacco Use | Biotech Hunter | Biotech Hunter